Step 1 topics → Hematology and Oncology → Anemia of Chronic Disease

Anemia of Chronic Disease

USMLE Step 1 trap: Attributes ACD to EPO deficiency rather than hepcidin-mediated functional iron sequestration. ACD is primarily caused by IL-6-driven hepcidin upregulation, which blocks ferroportin and traps iron in macrophages, causing functional iron deficiency despite adequate stores.

Anemia of chronic disease (ACD) — also called anemia of inflammation — is one of the highest-yield anemia topics on USMLE Step 1, and it's also one of the most frequently misunderstood. The core concept is this: in the setting of chronic inflammation (think rheumatoid arthritis, TB, cancer, HIV), IL-6 drives the liver to produce hepcidin, which degrades ferroportin on macrophages and enterocytes. The result is iron trapped in storage, unavailable for erythropoiesis — functional iron deficiency with full iron stores. That distinction is everything.

The exam tests this from multiple angles. Mechanism questions ask you to trace the IL-6 → hepcidin → ferroportin pathway. Diagnostic questions give you iron studies and ask you to distinguish ACD from iron deficiency anemia (IDA) — two conditions that look superficially similar but flip on ferritin and TIBC. Management questions describe a patient on oral iron who isn't responding and ask why. USMLE Step 1 loves this last angle because it exposes whether you understand the mechanism or just memorized 'give iron for iron deficiency.'

The tricky part is that ACD shares some features with IDA — both are microcytic (or normocytic in ACD), both have low serum iron — which makes students reach for the same treatment. The separating labs are ferritin (high in ACD, low in IDA) and TIBC (low in ACD, high in IDA). Students also confuse ACD with CKD anemia, which does involve EPO deficiency. ACD is not primarily an EPO problem — hepcidin is the driver. USMLE Step 1 will absolutely test whether you can keep those mechanisms straight.

From real student decks
81%have cards covering this topic
59%have mature cards

Common misconceptions

Common mistake
Wrong: ACD results from decreased EPO production, similar to CKD anemia.
Right: ACD is primarily caused by IL-6-driven hepcidin upregulation, which blocks ferroportin and traps iron in macrophages, causing functional iron deficiency despite adequate stores.
CKD anemia and ACD are related but mechanistically distinct — conflating them is a common Step 1 trap. CKD causes EPO deficiency because damaged kidneys can't produce it; EPO replacement works there. ACD is driven by IL-6 → hepcidin upregulation, which locks iron inside macrophages via ferroportin degradation. EPO levels in ACD are often appropriately elevated but simply can't be acted on without available iron. Always ask: is the problem making red cells, or getting iron to make them?
Common mistake
Wrong: Oral iron supplementation is effective treatment for ACD.
Right: Oral iron fails in ACD because elevated hepcidin blocks intestinal iron absorption via ferroportin degradation; treatment targets the underlying disease.
Oral iron requires functional intestinal ferroportin to move absorbed iron into the bloodstream. In ACD, elevated hepcidin degrades ferroportin on enterocytes, so iron you swallow stays in the gut epithelium and gets shed when those cells turn over — it never reaches the marrow. This is why giving oral iron in ACD doesn't move the needle: you're pouring water into a blocked pipe. Treatment must target the underlying inflammatory disease; in some cases IV iron or ESAs can be considered adjuncts.
Common mistake
Wrong: Ferritin is low in ACD because iron is unavailable for erythropoiesis.
Right: Ferritin is high in ACD because iron is sequestered inside macrophages and ferritin is also an acute-phase reactant elevated by inflammation.
Low ferritin means empty iron stores — that's IDA. In ACD, stores are full but inaccessible because hepcidin has blocked ferroportin on macrophages, trapping iron inside them. Ferritin reflects stored iron, and those stores are intact or even elevated. On top of that, ferritin is an acute-phase reactant, so the same inflammatory milieu driving ACD also directly raises ferritin levels. High ferritin in the context of low serum iron and low TIBC should immediately make you think ACD, not IDA.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Trace the molecular mechanism from chronic inflammation to anemia: how IL-6 upregulates hepcidin, how hepcidin degrades ferroportin, and why this traps iron in macrophages causing functional iron deficiency despite adequate total body iron stores.
  2. Distinguish the iron studies pattern of ACD from IDA: recognize that ACD shows low serum iron, low TIBC, and HIGH ferritin — opposite of what many students expect — because stored iron is sequestered and ferritin is an acute-phase reactant.
  3. Explain why oral iron supplementation fails in ACD and identify the correct management approach: elevated hepcidin blocks intestinal absorption via ferroportin, so the fix is treating the underlying inflammatory disease, not adding more iron.

Can you avoid these mistakes?

A patient with rheumatoid arthritis has Hgb 10.2, low serum iron, low TIBC, and ferritin of 180. What is the diagnosis, and what single cytokine is most responsible for the pathophysiology?
Your attending orders oral iron for a patient with Crohn's disease and suspected anemia of inflammation. The patient's anemia doesn't improve after 6 weeks. Explain mechanistically why oral iron failed in this setting.
Two patients both have low serum iron and microcytic anemia. One has rheumatoid arthritis and a ferritin of 200; the other has heavy menstrual bleeding and a ferritin of 4. Distinguish ACD from IDA using the iron studies — list the direction of serum iron, TIBC, and ferritin for each condition and explain why ferritin moves in opposite directions.
A vignette describes a patient with chronic HIV infection and normocytic anemia. Labs show elevated IL-6 and high ferritin. Another student says this looks like CKD anemia and suggests EPO supplementation. What is wrong with that reasoning, and what is the actual mechanism at play?

Related topics

Anemia Approach by MCV Hematopoiesis and Lineage Differentiation RBC Physiology and Lifespan WBC Differential and Function Platelet Physiology and Primary Hemostasis

See how your Anki deck covers this topic.

Upload your deck for a free audit →